These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28465209)

  • 1. Therapeutic glycoprotein production in mammalian cells.
    Lalonde ME; Durocher Y
    J Biotechnol; 2017 Jun; 251():128-140. PubMed ID: 28465209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoengineering in CHO Cells: Advances in Systems Biology.
    Tejwani V; Andersen MR; Nam JH; Sharfstein ST
    Biotechnol J; 2018 Mar; 13(3):e1700234. PubMed ID: 29316325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoengineering of Mammalian Expression Systems on a Cellular Level.
    Heffner KM; Wang Q; Hizal DB; Can Ö; Betenbaugh MJ
    Adv Biochem Eng Biotechnol; 2021; 175():37-69. PubMed ID: 29532110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation control technologies for recombinant therapeutic proteins.
    Gupta SK; Shukla P
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10457-10468. PubMed ID: 30334089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHO glycosylation mutants as potential host cells to produce therapeutic proteins with enhanced efficacy.
    Zhang P; Chan KF; Haryadi R; Bardor M; Song Z
    Adv Biochem Eng Biotechnol; 2013; 131():63-87. PubMed ID: 23142953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of bisected glycoforms of recombinant IFN-beta by overexpression of beta-1,4-N-acetylglucosaminyltransferase III in Chinese hamster ovary cells.
    Sburlati AR; Umaña P; Prati EG; Bailey JE
    Biotechnol Prog; 1998; 14(2):189-92. PubMed ID: 9548768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An 'omics approach towards CHO cell engineering.
    Datta P; Linhardt RJ; Sharfstein ST
    Biotechnol Bioeng; 2013 May; 110(5):1255-71. PubMed ID: 23322664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of therapeutic glycoproteins in glycoengineered plant: old farm for new crops.
    Kao MR; Karmarkar Saldivar R; Hsieh YSY
    Curr Opin Biotechnol; 2024 Jun; 87():103145. PubMed ID: 38781701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N-linked high mannose glycans.
    Shi HH; Goudar CT
    Biotechnol Bioeng; 2014 Oct; 111(10):1907-19. PubMed ID: 24975601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The art of CHO cell engineering: A comprehensive retrospect and future perspectives.
    Fischer S; Handrick R; Otte K
    Biotechnol Adv; 2015 Dec; 33(8):1878-96. PubMed ID: 26523782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in therapeutic glycoprotein production.
    Sethuraman N; Stadheim TA
    Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycan engineering and production of 'humanized' glycoprotein in yeast cells.
    Chiba Y; Akeboshi H
    Biol Pharm Bull; 2009 May; 32(5):786-95. PubMed ID: 19420743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate mammalian expression systems for biopharmaceuticals.
    Werner RG; Noé W; Kopp K; Schlüter M
    Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free protein expression based on extracts from CHO cells.
    Brödel AK; Sonnabend A; Kubick S
    Biotechnol Bioeng; 2014 Jan; 111(1):25-36. PubMed ID: 24018795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
    Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
    Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation.
    Könitzer JD; Müller MM; Leparc G; Pauers M; Bechmann J; Schulz P; Schaub J; Enenkel B; Hildebrandt T; Hampel M; Tolstrup AB
    Biotechnol J; 2015 Sep; 10(9):1412-23. PubMed ID: 26212696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHO-Omics Review: The Impact of Current and Emerging Technologies on Chinese Hamster Ovary Based Bioproduction.
    Stolfa G; Smonskey MT; Boniface R; Hachmann AB; Gulde P; Joshi AD; Pierce AP; Jacobia SJ; Campbell A
    Biotechnol J; 2018 Mar; 13(3):e1700227. PubMed ID: 29072373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of Unfolded Protein Response for Production of Biologics].
    Omasa T
    Yakugaku Zasshi; 2016; 136(6):831-9. PubMed ID: 27252063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells.
    Wong NS; Yap MG; Wang DI
    Biotechnol Bioeng; 2006 Apr; 93(5):1005-16. PubMed ID: 16432895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells.
    Mohan C; Kim YG; Koo J; Lee GM
    Biotechnol J; 2008 May; 3(5):624-30. PubMed ID: 18293320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.